Bayesian Adaptive Methods for Clinical Trials - Berry, Scott M. (Berry Consultants, College Station, Texas, USA); Carlin, Bradley P. (University of Minnesota, Minneapolis, USA); Lee, J. Jack (The University of Texas M.D. Anderson Cancer Center, H
61,99 €
inkl. MwSt.
Versandkostenfrei*
Versandfertig in 2-4 Wochen
payback
31 °P sammeln
  • Broschiertes Buch

Written by leading pioneers of Bayesian clinical trial designs, this book explores the growing role of Bayesian thinking in clinical trial analysis. Covering Phase I, II, and III clinical trials, it establishes the basic principles before extending them to specific phases and endpoints. The authors also discuss special topics that span different

Andere Kunden interessierten sich auch für
Produktbeschreibung
Written by leading pioneers of Bayesian clinical trial designs, this book explores the growing role of Bayesian thinking in clinical trial analysis. Covering Phase I, II, and III clinical trials, it establishes the basic principles before extending them to specific phases and endpoints. The authors also discuss special topics that span different
Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
Autorenporträt
Scott M. Berry is the President and Senior Statistical Scientist at Berry Consultants, a statistical consulting group specializing in adaptive clinical trial design in pharmaceutical and medical device research and development. Bradley P. Carlin is Mayo Professor in Public Health and Head of the Division of Biostatistics at the University of Minnesota. J. Jack Lee is Professor of Biostatistics at the University of Texas M.D. Anderson Cancer Center. Peter Müller is a Robert R. Herring Distinguished Professor in Clinical Research in the Department of Biostatistics at the University of Texas M.D. Anderson Cancer Center.